Aquestive Therapeutics AQST 深 沪
交易中 10-31 09:50:07 美东时间
6.665
+0.005
+0.08%
华盛通- 最 高6.68
- 今 开6.68
- 成交量 6.92万股
- 最 低 6.575
- 昨 收 6.66
- 总市值 8.06亿
- 52周最高 7.55
- 市盈率 静 --
- 换手率 0.06%
- 52周最低 2.12
- 委 比 37.46%
- 总股本 1.21亿
- 历史最高 20.696
- 量 比 2.87
- 振 幅 1.58%
- 历史最低 0.618
- 每 手 1
- 风险率 1.19%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Aquestive Therapeutics to Attend 2025 ACAAI Annual Meeting
Aquestive Therapeutics announced that multiple presentations on its investigational product Anaphylm™ (dibutepinephrine) sublingual film for severe allergic reactions, including anaphylaxis, will be featured at the 2025 ACAAI Annual Meeting in Orlando, FL. Presentations include a Phase 1 evaluation in pediatric patients and posters on pharmacokinetics and unmet needs in anaphylaxis care. Anaphylm, if approved, would be the first oral epinephrine ...
10-30 11:00
美股大行评级 | 潜在涨幅334.0%！HC Wainwright & Co.上调Inventiva目标价至24美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Inventiva"买入"评级，目标价从20美元升至24美元；摩根大通：维持BioMarin Pharmaceutical"超配"评级，目标价从116美元升至119美元
10-10 11:36
Aquestive gains after new patent wins for Anaphylm
Shares of Aquestive Therapeutics (NASDAQ:AQST) rose on Wednesday after the company announced that the U.S. regulators had issued two new patents covering its allergy therapy Anaphylm, which is current...
10-09 00:43
Aquestive Secures New Patents for Needle-Free Epinephrine Film to Treat Severe Allergies
Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery
10-08 19:01
Aquestive Therapeutics Broadens Patent Estate for Anaphylm™
USPTO has granted two additional patents for Aquestive Therapeutics' Anaphylm™, extending protection until 2037. Anaphylm is a sublingual epinephrine film designed to be the first oral treatment for severe allergic reactions, including anaphylaxis. Currently under FDA review, it offers a needle-free alternative. The patents cover its proprietary composition and technology platforms, reinforcing intellectual property and addressing unmet medical n...
10-08 11:00
Aquestive Therapeutics Advances Anaphylm Clinical Development
Aquestive Therapeutics ( ($AQST) ) has shared an announcement. Aquestive Therap...
10-01 20:58
ARS Pharma Urges FDA To Delay Approval Of Aquestive's Allergic Reaction Treatment
ARS Pharmaceuticals petitioned the FDA to delay approval of Aquestive's epinephrine film, citing safety, dosing, and cardiovascular concerns.
09-24 00:01
CoreWeave, Barrick Mining, FedEx And Other Big Stocks Moving Higher On Friday
U.S. stocks were higher, with the Nasdaq Composite gaining more than 100 points...
09-19 22:31
美股牛股 | 财报大超预期！Ciena科技大涨超23%，美鹰服饰涨近40%
两只绩优股大涨！Ciena科技涨超23%，四季度收入指引为13.2亿美元；美鹰服饰涨近40%，每股收益达0.45美元，大超市场预期>>
09-05 19:03
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Bone Biologics (NASDAQ:BBLG) shares increased by 30.4% to $2.7 during ...
09-04 20:08
